Cargando…

The influence of smoking and other risk factors on the outcome after radiochemotherapy for anal cancer

BACKGROUND: Smoking is an important risk factor for the development of cancer. Smoking during radiochemotherapy therapy may have a negative influence on prognosis. We evaluated the effect of smoking during radiochemotherapy on the outcome for patients with anal cancer. METHODS: Sixty-eight patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mai, Sabine Kathrin, Welzel, Grit, Haegele, Verena, Wenz, Frederik
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2078591/ https://www.ncbi.nlm.nih.gov/pubmed/17711570 http://dx.doi.org/10.1186/1748-717X-2-30

Ejemplares similares

Acute small-bowel toxicity during neoadjuvant combined radiochemotherapy in locally advanced rectal cancer: determination of optimal dose-volume cut-off value predicting grade 2–3 diarrhoea
por: Reis, Tina, et al.
Publicado: (2015)

Factors of influence on acute skin toxicity of breast cancer patients treated with standard three-dimensional conformal radiotherapy (3D-CRT) after breast conserving surgery (BCS)
por: Kraus-Tiefenbacher, Uta, et al.
Publicado: (2012)

Treatment outcome after radiochemotherapy in anal cancer patients staged with (18)F-FDG-PET-CT
por: Braun, L.H., et al.
Publicado: (2020)

Dose-escalated salvage radiotherapy after radical prostatectomy in high risk prostate cancer patients without hormone therapy: outcome, prognostic factors and late toxicity
por: Shelan, Mohamed, et al.
Publicado: (2013)

Quality of life in patients treated with radiochemotherapy for primary diagnosis of anal cancer
por: Sauter, Christina, et al.
Publicado: (2022)

Long-term outcome after combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) for vertebral tumors
por: Bludau, Frederic, et al.
Publicado: (2020)

Quality of life after low-dose rate-brachytherapy for prostate carcinoma – long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series
por: Buergy, Daniel, et al.
Publicado: (2018)

Prospective Comparison of Hypofractionated Versus Normofractionated Intensity-Modulated Radiotherapy in Breast Cancer: Late Toxicity Results of the Non-Inferiority KOSIMA Trial (ARO2010-3)
por: Sarria, Gustavo R., et al.
Publicado: (2022)

Genital invasion or perigenital spread may pose a risk of marginal misses for Intensity Modulated Radiotherapy (IMRT) in anal cancer
por: Koeck, Julia, et al.
Publicado: (2016)

A fast radiotherapy paradigm for anal cancer with volumetric modulated arc therapy (VMAT)
por: Stieler, Florian, et al.
Publicado: (2009)

Combined Radiochemotherapy: Metalloproteinases Revisited
por: Waller, Verena, et al.
Publicado: (2021)

Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A
por: Welzel, Grit, et al.
Publicado: (2013)

Radiochemotherapy
Publicado: (1998)

Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II Trials
por: Kripp, M., et al.
Publicado: (2015)

Longitudinal cosmetic outcome after planned IORT boost with low kV X-rays—monocentric results from the TARGIT BQR registry
por: Goerdt, Lukas, et al.
Publicado: (2023)

A cohort analysis to identify eligible patients for intraoperative radiotherapy (IORT) of early breast cancer
por: Sperk, Elena, et al.
Publicado: (2014)

Volumetric Modulated Arc Therapy Improves Outcomes in Definitive Radiochemotherapy for Anal Cancer Whilst Reducing Acute Toxicities and Increasing Treatment Compliance
por: Possiel, Jacqueline, et al.
Publicado: (2021)

Impact of Smoking on Anal Abscess and Anal Fistula Diseases
por: Zheng, Li-Hua, et al.
Publicado: (2018)

RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: A randomized multicenter phase II trial
por: Martin, Daniel, et al.
Publicado: (2020)

Influence of rectal prolapse on the asymmetry of the anal sphincter in patients with anal incontinence
por: Damon, Henri, et al.
Publicado: (2003)

Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
por: Summerer, Isolde, et al.
Publicado: (2013)

Influence of Gender on Radiosensitivity during Radiochemotherapy of Advanced Rectal Cancer
por: Schuster, Barbara, et al.
Publicado: (2021)

TARGIT-E(lderly)—Prospective phase II study of intraoperative radiotherapy (IORT) in elderly patients with small breast cancer
por: Neumaier, Christian, et al.
Publicado: (2012)

Erratum: Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients
por: Summerer, Isolde, et al.
Publicado: (2015)

Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
por: Lewitzki, Victor, et al.
Publicado: (2019)

SDF-1/CXCR4 expression in head and neck cancer and outcome after postoperative radiochemotherapy
por: De-Colle, Chiara, et al.
Publicado: (2017)

Concurrent radiochemotherapy in advanced hypopharyngeal cancer
por: Krstevska, Valentina, et al.
Publicado: (2010)

Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma
por: Oblak, Irena, et al.
Publicado: (2014)

Ösophaguskarzinom: Prognoseverbesserung durch neoadjuvante Radiochemotherapie
por: Knippen, Stefan, et al.
Publicado: (2021)

INTRAGO: intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study
por: Giordano, Frank A, et al.
Publicado: (2014)

Obstetrical and epidemiological factors influence the severity of anal incontinence after obstetric anal sphincter injury
por: Joris, France, et al.
Publicado: (2019)

Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
por: Niewald, Marcus, et al.
Publicado: (2011)

Salvage laryngectomy after primary radio- and radiochemotherapy: A retrospective study
por: Sievert, Matti, et al.
Publicado: (2021)

Tumor Volume Regression during and after Radiochemotherapy: A Macroscopic Description
por: Castorina, Paolo, et al.
Publicado: (2022)

Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme
por: Seidlitz, Annekatrin, et al.
Publicado: (2015)

RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV
por: Lorenzen, Sylvie, et al.
Publicado: (2020)

Triapine Radiochemotherapy in Advanced Stage Cervical Cancer
por: Kunos, Charles A., et al.
Publicado: (2018)

Relationship between anal cancer recurrence and cigarette smoking
por: McMahon, Kevin R, et al.
Publicado: (2023)

Anal squamous cell carcinoma: Impact of radiochemotherapy evolution over years and an explorative analysis of MRI prediction of tumor response in a mono-institutional series of 131 patients
por: Bonù, Marco Lorenzo, et al.
Publicado: (2022)

Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trial
por: Wiegand, Susanne, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3b1qc7isaqbp846q8kh2acpph1